Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 42

Sort by

Sort Order Select

Journal Articles

Real World Evidence of Prescription Patterns and Effect of Oxbryta (voxelotor) for Patients with Sickle Cell Disease

Nirmish Shah, MD, Ahmar Urooj Zaidi, MD, Michael U. Callaghan, MD, Darla Liles, MD, Clarissa E. Johnson, MD, Laura M De Castro, MD MHSc

Blood (2020) 136 (Supplement 1): 31–32.

https://doi.org/10.1182/blood-2020-143434

Published: 2020

Journal Articles

The Impact of Hemoglobin Level on Risk of End-Organ Damage among Patients with Sickle Cell Disease - A Large-Scale, Longitudinal Analysis

William B Ershler, MD, Laura M De Castro, MD MHSc, Zahra Pakbaz, MD, Aaron Moynahan, Derek Weycker, PhD, Nhat Pham, Thomas E Delea, MSIA, Irene Agodoa, MD, Ze Cong, PhD

Blood (2020) 136 (Supplement 1): 27–28.

https://doi.org/10.1182/blood-2020-140572

Published: 2020

Journal Articles

Healthcare Utilization Patterns and Health Quality Indicators in Sickle Cell Disease Patients Transitioning from Pediatric to Adulthood

Akshaya Arjunan, BS, Deborah Moss, MD MPH, Laura M. De Castro, MD

Blood (2018) 132 (Supplement 1): 3513.

https://doi.org/10.1182/blood-2018-99-117558

Published: 2018

Journal Articles

The Conundrum of Hydroxyurea Use and Health Care Utilization in Sickle Cell Disease

Akshaya Arjunan, BS, Deborah Moss, MD MPH, Sydna B. Burns, Laura M. De Castro, MD

Blood (2018) 132 (Supplement 1): 2282.

https://doi.org/10.1182/blood-2018-99-117735

Published: 2018

Journal Articles

Using Social Media to Assess Patient and Family Perceptions of Bone Marrow Transplant, Gene Therapy and Other Potentially Curative Treatments for Sickle Cell Disease (SCD)

Charles Jonassaint, PhD, Aisha L Walker, PhD MPH, Rosta Farzan, PhD, Laura M. De Castro, MD, Tosin Ola, BSN, RN, Lakiea Bailey, PhD

Blood (2016) 128 (22): 5921.

https://doi.org/10.1182/blood.V128.22.5921.5921

Published: 2016

Journal Articles

The Impact of Cognitive Function on Adherence to Hydroxyurea Therapy in Patients with Sickle Cell Disease

Cristina Merkhofer, MD, Susan Sylvester, MS, BSN, RN, CCM, Michelle Zmuda, Jude Jonassaint, RN, Laura M. De Castro, MD, Gregory J Kato, MD, Meryl A. Butters, PhD, Enrico M. Novelli, MD MS

Blood (2016) 128 (22): 2493.

https://doi.org/10.1182/blood.V128.22.2493.2493

Published: 2016

Journal Articles

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use

Marilyn J. Telen, Ted Wun, Timothy L. McCavit, Laura M. De Castro, Lakshmanan Krishnamurti, Sophie Lanzkron, Lewis L. Hsu, Wally R. Smith, Seungshin Rhee, John L. Magnani, Helen Thackray

Blood (2015) 125 (17): 2656–2664.

https://doi.org/10.1182/blood-2014-06-583351

Published: 2015

Includes: Supplemental data

Journal Articles

Sickle Cell Crisis: Safety Of a High-Dose Opioid Protocol In The Emergency Department

Paula Tanabe, PhD, RN, FAEN, FAAN, Judith Paice, PhD, RN, FAAN, Zoran Martinovich, PhD, Laura M. De Castro, MD

Blood (2013) 122 (21): 5579.

https://doi.org/10.1182/blood.V122.21.5579.5579

Published: 2013

Journal Articles

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

Laura M. De Castro, MD, Ted Wun, MD, Sophie Lanzkron, MD MHS, Wally R. Smith, MD, Kathryn L. Hassell, MD, Abdullah Kutlar, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 775.

https://doi.org/10.1182/blood.V122.21.775.775

Published: 2013

Journal Articles

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Marilyn J. Telen, MD, Ted Wun, MD, Timothy L. McCavit, MD, MS, Laura M. De Castro, MD, Lakshmanan Krishnamurti, MD, Sophie Lanzkron, MD, MHS, Lewis L. Hsu, MD, PhD, Wally R. Smith, MD, Seungshin Rhee, MS, John L. Magnani, PhD, Helen Thackray, MD

Blood (2013) 122 (21): 776.

https://doi.org/10.1182/blood.V122.21.776.776

Published: 2013

Journal Articles

Genetic and Epigenetic Regulation of the Gamma Globin Locus Is Associated with Fetal Hemoglobin Levels and Frequency of Pain in Sickle Cell Disease

Blair Anderson, Ebenezer Enchia, Karen Soldano, B.S., Melanie Garrett, MS, Jude Jonassaint, RN, Laura M. De Castro, MD, Marilyn J. Telen, MD, Allison E Ashley-Koch, PhD

Blood (2012) 120 (21): 3230.

https://doi.org/10.1182/blood.V120.21.3230.3230

Published: 2012

Journal Articles

Information Technology Use by Patients with Hemoglobinopathies

Jude Jonassaint, RN, Laura M. De Castro, MD

Blood (2012) 120 (21): 4698.

https://doi.org/10.1182/blood.V120.21.4698.4698

Published: 2012

Journal Articles

A Randomized Trial of the Safety and Benefit of Transfusion Vs. Standard Care In the Prevention of Sickle Cell-Related Complications In Adults: a Preliminary Report From the Phase II NHLBI Comprehensive Sickle Cell Centers (CSCC) Study of Neuropsychological Dysfunction and Neuroimaging Abnormalities In Neurologically Intact Adult Patients with Sickle Cell Disease

Blood (2010) 116 (21): 3221.

https://doi.org/10.1182/blood.V116.21.3221.3221

Published: 2010

Journal Articles

Genetic Variation In MYH9 Is Associated with Sickle Cell Disease Nephropathy

Emmanuel Okocha, MBBS, Melanie Garrett, MS, Karen Soldano, BS, Laura M. De Castro, MD, Jude Jonassaint, RN, Eugene P. Orringer, MD, James R. Eckman, MD, Marilyn J. Telen, MD, Allison E Ashley-Koch, PhD

Blood (2010) 116 (21): 1648.

https://doi.org/10.1182/blood.V116.21.1648.1648

Published: 2010

Journal Articles

GMI-1070, a Pan-Selectin Inhibitor: Safety and PK In a Phase 1/2 Study In Adults with Sickle Cell Disease

Lori Styles, MD, Ted Wun, MD, FACP, FRCPA, Laura M. De Castro, MD, Marilyn J. Telen, MD, William Kramer, PhD, Henry Flanner, John L Magnani, PhD, Helen Thackray, MD

Blood (2010) 116 (21): 1632.

https://doi.org/10.1182/blood.V116.21.1632.1632

Published: 2010

Journal Articles

Advance Care Planning In Adults with Sickle Cell Disease (SCD)

Frederick Bartholomew, BS, Laura M. De Castro, MD

Blood (2010) 116 (21): 391.

https://doi.org/10.1182/blood.V116.21.391.391

Published: 2010

Journal Articles

Effects of GMI-1070, a Pan-Selectin Inhibitor, on Leukocyte Adhesion In Sickle Cell Disease: Results From a Phase 1/2 Study

Ted Wun, MD, Laura M. De Castro, MD, Lori Styles, MD, Anthony Cheung, MD, Shannon Chase, Scott I Simon, PhD, John L Magnani, PhD, Helen Thackray, MD

Blood (2010) 116 (21): 262.

https://doi.org/10.1182/blood.V116.21.262.262

Published: 2010

Journal Articles

Retrospective Review of the Natural History of Pulmonary Hypertension in Sickle Cell Disease Demonstrates That Progressive Enlargement of the Left Atrium Is a Strong Predictor of Death.

Damian Silbermins, MD, Agustin Calatroni, MS, Jude Jonassaint, RN, Marilyn J. Telen, MD, Laura M. De Castro, MD

Blood (2009) 114 (22): 1529.

https://doi.org/10.1182/blood.V114.22.1529.1529

Published: 2009

Journal Articles

The Complex Relationship Between Sickle Cell Disease and Depression.

Soheir S. Adam, M.D., Charlene Flahiff, M.S., Mary R Abrams, MPH, Marilyn J. Telen, MD, Laura M. De Castro, MD

Blood (2009) 114 (22): 2585.

https://doi.org/10.1182/blood.V114.22.2585.2585

Published: 2009

Journal Articles

Prolonged Survival despite High Disease Burden in Elderly (≥55) Patients with Hb SS or Hb Sβ0 Thalassemia

Damian Silbermins, MD, Laura M. De Castro, MD, Allison E Ashley-Koch, PhD, Jude C Jonassaint, RN, Melanie E. Garrett, MS, James R. Eckman, MD, Eugene P. Orringer, MD, Marilyn J. Telen, MD

Blood (2008) 112 (11): 710.

https://doi.org/10.1182/blood.V112.11.710.710

Published: 2008

NARROW

Real World Evidence of Prescription Patterns and Effect of Oxbryta (voxelotor) for Patients with Sickle Cell Disease

The Impact of Hemoglobin Level on Risk of End-Organ Damage among Patients with Sickle Cell Disease - A Large-Scale, Longitudinal Analysis

Healthcare Utilization Patterns and Health Quality Indicators in Sickle Cell Disease Patients Transitioning from Pediatric to Adulthood

The Conundrum of Hydroxyurea Use and Health Care Utilization in Sickle Cell Disease

Using Social Media to Assess Patient and Family Perceptions of Bone Marrow Transplant, Gene Therapy and Other Potentially Curative Treatments for Sickle Cell Disease (SCD)

The Impact of Cognitive Function on Adherence to Hydroxyurea Therapy in Patients with Sickle Cell Disease

Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use

Sickle Cell Crisis: Safety Of a High-Dose Opioid Protocol In The Emergency Department

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Genetic and Epigenetic Regulation of the Gamma Globin Locus Is Associated with Fetal Hemoglobin Levels and Frequency of Pain in Sickle Cell Disease

Information Technology Use by Patients with Hemoglobinopathies

Genetic Variation In MYH9 Is Associated with Sickle Cell Disease Nephropathy

GMI-1070, a Pan-Selectin Inhibitor: Safety and PK In a Phase 1/2 Study In Adults with Sickle Cell Disease

Advance Care Planning In Adults with Sickle Cell Disease (SCD)

Effects of GMI-1070, a Pan-Selectin Inhibitor, on Leukocyte Adhesion In Sickle Cell Disease: Results From a Phase 1/2 Study

Retrospective Review of the Natural History of Pulmonary Hypertension in Sickle Cell Disease Demonstrates That Progressive Enlargement of the Left Atrium Is a Strong Predictor of Death.

The Complex Relationship Between Sickle Cell Disease and Depression.

Prolonged Survival despite High Disease Burden in Elderly (≥55) Patients with Hb SS or Hb Sβ0 Thalassemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only